Stay always up-to-datewith our corporate news
The new Group company is based in Vienna and is led by Patrick Heil, who combines this role with that of General Manager for Switzerland.
Operating profit impacted by market expansion activities and currency effects
Ypsomed today announces the acquisition of ICU Medical, Inc.’s Orbit diabetes infusion set business. With this acquisition, Ypsomed strengthens its position in the diabetes sector.
B. Braun is to distribute the reusable insulin pen Omnifill, developed by the Burgdorf-based diabetes specialist, together with its human insulins
The Technology and Operations division are now directly represented on the management board of the Burgdorf-based diabetes specialist
Shares of Ypsomed Holding AG now in the Domestic Standard of the SIX Swiss Exchange
In early 2012, Ypsomed is to launch the second generation OmniPod insulin patch pump
Ypsomed Holding AG to switch financial reporting standards from IFRS to Swiss GAAP ARR
Richard Fritschi is leaving Ypsomed. Dr. h. c. Willy Michel will assume the roles of CEO and chairman of the Ypsomed Group.
In Germany, already one in three new pump users decide to use the mylife OmniPod insulin patch pump
Ypsomed is on the right track – However, the transformation takes longer
The new mylife Roto infusion set with 360-degree freedom of movement